170 related articles for article (PubMed ID: 22388757)
1. Stem cell-related markers in primary breast cancers and associated metastatic lesions.
Guler G; Balci S; Costinean S; Ussakli CH; Irkkan C; Suren D; Sari E; Altundag K; Ozisik Y; Jones S; Bacher J; Shapiro CL; Huebner K
Mod Pathol; 2012 Jul; 25(7):949-55. PubMed ID: 22388757
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell and epithelial-mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast.
Oon ML; Thike AA; Tan SY; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):31-41. PubMed ID: 25677743
[TBL] [Abstract][Full Text] [Related]
3. High GD2 expression defines breast cancer cells with enhanced invasiveness.
Mansoori M; Roudi R; Abbasi A; Abolhasani M; Abdi Rad I; Shariftabrizi A; Madjd Z
Exp Mol Pathol; 2019 Aug; 109():25-35. PubMed ID: 31075227
[TBL] [Abstract][Full Text] [Related]
4. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
[TBL] [Abstract][Full Text] [Related]
5. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.
Tiezzi DG; Valejo FA; Marana HR; Carrara HH; Benevides L; Antonio HM; Sicchieri RD; Milanezi CM; Silva JS; de Andrade JM
Med Oncol; 2012 Sep; 29(3):1479-85. PubMed ID: 21713550
[TBL] [Abstract][Full Text] [Related]
6. ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24- phenotype.
Zhong Y; Shen S; Zhou Y; Mao F; Guan J; Lin Y; Xu Y; Sun Q
Med Oncol; 2014 Mar; 31(3):864. PubMed ID: 24519209
[TBL] [Abstract][Full Text] [Related]
7. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
Zhu J; He J; Liu Y; Simeone DM; Lubman DM
J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
[TBL] [Abstract][Full Text] [Related]
8. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
[TBL] [Abstract][Full Text] [Related]
9. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas.
Oliveira-Costa JP; Zanetti JS; Silveira GG; Soave DF; Oliveira LR; Zorgetto VA; Soares FA; Zucoloto S; Ribeiro-Silva A
Diagn Pathol; 2011 Aug; 6():73. PubMed ID: 21824412
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
13. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Vellon L; Menendez JA
Cell Cycle; 2011 Nov; 10(22):3871-85. PubMed ID: 22127234
[TBL] [Abstract][Full Text] [Related]
14. Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition.
Zhang Y; Toy KA; Kleer CG
Mod Pathol; 2012 Feb; 25(2):178-84. PubMed ID: 22080057
[TBL] [Abstract][Full Text] [Related]
15. CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms.
Soave DF; Oliveira da Costa JP; da Silveira GG; Ianez RC; de Oliveira LR; Lourenço SV; Ribeiro-Silva A
Diagn Pathol; 2013 Feb; 8():29. PubMed ID: 23419168
[TBL] [Abstract][Full Text] [Related]
16. Axillary Skip Metastases and the False-Negative Rate of Sentinel Lymph Node Biopsy in Patients With Breast Cancer Are Related to Negative ALDH-1 Expression and Ki-67 Expression.
Kim WG; Lee J
Int J Surg Pathol; 2017 Aug; 25(5):397-405. PubMed ID: 28145149
[TBL] [Abstract][Full Text] [Related]
17. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
19. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
20. Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
Leng X; Huang G; Li S; Yao M; Ding J; Ma F
PLoS One; 2021; 16(12):e0261138. PubMed ID: 34932597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
